19,188 Shares in Corteva, Inc. $CTVA Bought by MidFirst Bank

MidFirst Bank purchased a new position in Corteva, Inc. (NYSE:CTVA) in the second quarter, Holdings Channel.com reports. The firm purchased 19,188 shares of the company’s stock, valued at approximately $1,625,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Arbejdsmarkedets Tillaegspension bought a new stake in shares of Corteva during the fourth quarter valued at approximately $23,679,000. Leonteq Securities AG purchased a new position in shares of Corteva in the fourth quarter worth $2,350,000. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Corteva by 23.5% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock worth $7,378,000 after acquiring an additional 20,957 shares during the last quarter. Brandes Investment Partners LP boosted its position in shares of Corteva by 1.1% during the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after acquiring an additional 24,985 shares during the last quarter. Finally, Twin Capital Management Inc. grew its stake in Corteva by 178.9% during the fourth quarter. Twin Capital Management Inc. now owns 25,394 shares of the company’s stock valued at $1,702,000 after acquiring an additional 16,288 shares in the last quarter. 81.54% of the stock is owned by institutional investors.

Corteva Price Performance

Corteva stock opened at $75.73 on Tuesday. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $90.97. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm’s fifty day moving average is $81.78 and its 200 day moving average is $80.09. The company has a market cap of $50.53 billion, a price-to-earnings ratio of 50.15, a PEG ratio of 2.35 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same period last year, the company posted $2.20 EPS. The business’s revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 1.0%. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CTVA. Barclays lifted their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. Jefferies Financial Group raised their price objective on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Mizuho lifted their target price on Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. CICC Research boosted their target price on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Finally, Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $91.70.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.